Report - Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in … · 2019. 12. 19. · of β-thalassemia intermedia (Figure 1A). The clinical compound, VIT-2763 (Figure 1B)

Please pass captcha verification before submit form